Inscopix @ Neuroscience 2017
It’s been five years since our very first SfN – New Orleans 2012. I still fondly remember that first SfN. There were five of us, and that was the entire company. We launched nVista that year, our first product based on the miniature, integrated microscope for large-scale calcium imaging in freely behaving rodents that we’d invented at Stanford. nVista’s launch, and Inscopix’s launch, marked the dawn of a new category of tools for neuroscience research. As many of you know we started selling nVista through the Neuroscience Early Access Program, whose goal was to not just recruit a critical mass of early adopter labs, but to also enable a critical mass of circuit neuroscience research with nVista.
Five years since that first SfN, and four years since nVista first began shipping, I am incredibly proud to say that discoveries are being made, scientific publications with nVista and Inscopix’s solutions are increasing by the month, and a new generation of graduate students and postdocs are literally launching their careers with the beautiful stories of circuit function that they are unravelling. This year alone we have seen close to 20 scientific publications from the Inscopix Community, and more than 40 publications cumulatively. At SfN, you will see about 50 posters and talks from the Inscopix Community. We are proud of your work, and we are honored to have been a part of making your scientific dreams come true. We also thank you, especially the earliest of the Early Adopters who enrolled in our Neuroscience Early Access Program, for investing in us, trusting us, and for providing critical feedback that has helped us improve. You are pioneers, and we will always be grateful for the bet you took on a young company.
We care, and I personally care, about bringing the success that our pioneers and early adopters are enjoying to everyone – to all of you here today and to the entire neuroscience research community. This means lowering barriers to adoption. That is the essence of what we’ve always preached with our mantra of integrated, end-to-end solutions for circuit neuroscience. We have always believed that if we can not only make our instrumentation as plug-and-play as possible, but also provide the researcher with a more optimized workflow from ready-to-image viruses to easy-to-use software for processing and analyzing data, then hopefully we can truly lower the barriers for any investigator interested in understanding the brain at the level of its circuits.
At this year’s SfN, we are delivering on this vision. We are launching the next-generation in nVista instrumentation – with a ton of new features, all designed to make calcium imaging easy, reliable, and fun. We are accelerating the roll-out of our ready-to-image viruses so that you can skip tedious and time-consuming serial dilutions and get to imaging right away. And equally importantly, we are launching a completely overhauled data processing suite to help you make sense of your data faster. We are also still offering all these new products as part of our standard product packages, at the same prices. Oh, and did I mention that as a member of the Inscopix Community, you now get a Field Scientist Consultant (FSCs) for no additional charge? Our FSCs will visit your lab and work with you from experimental design to data analysis, and from grant to manuscript submissions. They are world-class scientists, your peers at the bench, whose only reward is in seeing you succeed in your science.
So if there’s one message that I want you all to leave with today, it’s this: Inscopix cares about making itself accessible to all – we are committed to empowering you, no matter who you are and no matter where your lab is in the world. If you are truly interested in doing great science, and if you truly care about getting to reproducible results affordably, without burning valuable time and cash, then come join us, come join our community. Be a part of this movement that generates perhaps greater than a hundred scientific publications by SfN 2018, and that begins to make the conceptual advances in neuroscience that we are all so desperately in search of.